Market Tracker

11/17 5:15pm ET

Cambrex Corp (NYSE:CBM)

48.10
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
42.55
Today|||52-Week Range
62.95
-10.84%
Year-to-Date
No recent news for Cambrex Corp.

Today’s Trading

Previous close48.10
Today’s open48.30
Day’s range47.85 - 49.20
Volume513,115
Average volume (3 months)369,306
Market cap$1.6B
Dividend yield--
Data as of 4:02pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)+40.91%
Earnings growth (this year)+7.93%
Earnings growth (next 5 years)+13.50%
Revenue growth (last year)+13.23%
P/E ratio15.8
Price/Sales3.63
Price/Book3.84

Competitors

 Today’s
change
Today’s
% change
TBPHTheravance Biopharma...0.000.00%
CORTCorcept Therapeutics...0.000.00%
ARRYArray Biopharma Inc0.000.00%
RGENRepligen Corp0.000.00%
Data as of 4:00pm ET, 11/17/2017

Financials

Next reporting dateFebruary 7, 2018
EPS forecast (this quarter)$1.15
Annual revenue (last year)$490.6M
Annual profit (last year)$81.7M
Net profit margin17.80%

Profile

Sector
Process Industries
Industry
Chemicals: Specialty
President, Chief Executive Officer &
Director
Steven M. Klosk
Chief Operating Officer &
Executive Vice President
Shawn P. Cavanagh
Corporate headquarters
East Rutherford, New Jersey

Forecasts